Edwards Lifesciences Corp. stock rises Thursday, outperforms market
Shares of Edwards Lifesciences Corp. EW, +0.42% inched 0.42% higher to $67.71 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX, +0.38% rising 0.38% to 4,567.80 and the Dow Jones Industrial Average DJIA, +1.47% rising 1.47% to 35,950.89.
This was the stock's second consecutive day of gains.
Edwards Lifesciences Corp. closed $27.16 short of its 52-week high ($94.87), which the company reached on June 30th.
The stock underperformed when compared to some of its competitors Thursday, as Abbott Laboratories ABT, +0.64% rose 0.64% to $104.29, Medtronic +0.52% rose 0.52% to $79.27, and Stryker Corp. SYK, +0.67% rose 0.67% to $296.33.
Trading volume (7.1 M) eclipsed its 50-day average volume of 4.4 M.
Editor's Note: This story was auto-generated by Automated Insights , an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
!["Elevance Health Inc. stock outperforms market on strong trading day"](https://img.theflashnews.co/"us/resources/article_images/a09119d9-8f01-4784-8c32-c695735a4da1.jpg"?h=157&w=320&mode=stretch)
